What is Pituitary Apoplexy?
Pituitary apoplexy is a life-threatening acute pituitary infarction, hemorrhage, and/or necrosis that presents as rapid onset headache and may include vomiting, fever, meningismus, vision abnormalities, and changes in mental status 1.
Clinical Presentation
The condition manifests with:
- Sudden severe headache (most common presenting symptom)
- Visual disturbances including field defects, decreased visual acuity, or diplopia
- Cranial nerve palsies (particularly affecting eye movements)
- Altered mental status ranging from confusion to coma
- Nausea and vomiting
- Signs of meningeal irritation (neck stiffness, photophobia)
- Hormonal dysfunction with partial or complete hypopituitarism 1, 2
Pathophysiology and Risk Factors
Pituitary apoplexy typically occurs from hemorrhagic or vascular impairment of the pituitary gland, most commonly within a pre-existing pituitary adenoma (often non-functioning) 2, 3. The exact mechanism remains incompletely understood, though tumor overgrowth of its blood supply is the leading theory 4.
Key predisposing factors include:
- Pre-existing pituitary adenomas
- Postpartum period (Sheehan syndrome)
- Diabetes mellitus and hypertension
- Anticoagulation therapy
- Prior radiation treatment
- Trauma
- Sickle cell anemia
- Acute shock states 2, 3, 4
Why This is Life-Threatening
Partial or complete hypopituitarism is a prominent feature and contributes to high mortality 1. The most critical immediate threat is acute secondary adrenal insufficiency (AI), which is a major cause of mortality 1. The rapid increase in intrasellar pressure can cause sudden pituitary dysfunction, though diabetes insipidus is relatively uncommon (4% transient, 2% persistent) due to differences in anterior versus posterior pituitary blood supply 1.
Diagnostic Approach
MRI using high-resolution protocols is the primary modality for evaluation 2. Imaging demonstrates:
- Tumor enlargement and sellar expansion
- Intratumoral hemorrhage (T1 hyperintensity, low T2 signal, or hemorrhage fluid level)
- Mass effect on optic chiasm or nerves 2
CT may be used in emergency settings when rapid diagnosis is needed to exclude intracranial hemorrhage, but is less sensitive than MRI for detecting acute pituitary hemorrhage 2.
All patients require immediate testing for acute pituitary insufficiency 1.
Critical Management Principles
Because acute AI is a major cause of mortality, glucocorticoid therapy must be initiated immediately until laboratory diagnosis is established and normal pituitary function is confirmed 1.
Immediate Hormonal Management:
When patients cannot tolerate oral medications, begin with:
- 100-200 mg IV hydrocortisone bolus
- Followed by 2-4 mg/h continuous infusion OR 50-100 mg injections every 6 hours
- Rapidly taper as indicated and transition to standard oral maintenance doses 1
High-dose glucocorticoids may also improve visual outcomes 1.
Treatment Strategy Selection
Transsphenoidal decompression and immediate high-dose IV corticosteroid replacement therapy are the standard of care 1. However, conservative management is advocated for carefully selected patients 1.
Indications for Surgery:
- Visual disturbance (decreased acuity or field defects)
- Severe or progressive neurological compromise
- Clinical deterioration despite conservative management 5, 6
Conservative Management Candidates:
Important caveat: A multicentre prospective registry of 97 patients showed that 3 months after apoplexy, surgery did not confer benefit in improving vision compared with conservative management, and timing of surgery (≤3 days versus >3 days) did not affect outcomes 7. However, surgery was performed in more severely ill patients, limiting generalizability.
Long-Term Outcomes and Monitoring
Hypopituitarism may be permanent or transient, with recovery occurring from weeks to months 1. More than 50% of patients eventually require hormonal replacement 1.
All patients require monitoring of pituitary axes whether treated surgically or conservatively, as hypopituitarism may develop over time 1. There is no consensus on whether surgical treatment improves long-term pituitary function, though some studies report increased hormonal deficiencies with conservative management 1.
Clinical Pitfalls
- Not all intrapituitary hemorrhage seen on imaging represents symptomatic apoplexy—approximately 25% of patients have signs of prior subclinical hemorrhage 7
- Diabetes insipidus is uncommon (only 6% total incidence), so its absence should not exclude the diagnosis 1
- In young patients, presentation may be subacute rather than fulminant, potentially delaying diagnosis 6
- Marked hyperprolactinemia can occur from stalk compression (stalk effect) rather than a prolactinoma, creating diagnostic confusion 6